2023年国际肿瘤免疫治疗大会：癌症免疫治疗协会第20届年会报告
CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy.
作者信息
Dallmann J, Freitag J, Jung C, Khinvasara K, Merz L, Peters D, Schork M, Beck J D
机构信息
Immunotherapies & Preclinical Research, BioNTech SE, Mainz.
TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
出版信息
Immunooncol Technol. 2023 Sep 12;20:100397. doi: 10.1016/j.iotech.2023.100397. eCollection 2023 Dec.
Abstract
The Association for Cancer Immunotherapy (CIMT) celebrated the 20th anniversary of the CIMT Annual Meeting. CIMT2023 was held 3-5 May 2023 in Mainz, Germany. 1051 academic and clinical professionals from over 30 countries attended the meeting and discussed the latest advances in cancer immunology and immunotherapy research. This report summarizes the highlights of CIMT2023.
摘要
癌症免疫治疗协会（CIMT）庆祝了CIMT年会成立20周年。CIMT2023于2023年5月3日至5日在德国美因茨举行。来自30多个国家的1051名学术和临床专业人员参加了会议，讨论了癌症免疫学和免疫治疗研究的最新进展。本报告总结了CIMT2023的亮点。
相似文献
1
CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy.
Immunooncol Technol. 2023 Sep 12;20:100397. doi: 10.1016/j.iotech.2023.100397. eCollection 2023 Dec.
2
CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2381925. doi: 10.1080/21645515.2024.2381925. Epub 2024 Jul 23.
3
CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2124785. doi: 10.1080/21645515.2022.2124785. Epub 2022 Oct 12.
4
CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy.
Hum Vaccin Immunother. 2022 Dec 31;18(1):2024416. doi: 10.1080/21645515.2021.2024416. Epub 2022 Feb 7.
5
CIMT 2018: Pushing frontiers in cancer immunotherapy - Report on the 16 Annual Meeting of the Association for Cancer Immunotherapy.
Hum Vaccin Immunother. 2018;14(12):2864-2873. doi: 10.1080/21645515.2018.1504526. Epub 2018 Aug 29.
6
CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, Germany.
Hum Vaccin Immunother. 2016 Nov;12(11):2805-2812. doi: 10.1080/21645515.2016.1206677. Epub 2016 Jul 19.
7
CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.
Hum Vaccin Immunother. 2013 Sep;9(9):2025-32. doi: 10.4161/hv.25768. Epub 2013 Jul 22.
8
Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10-12, 2016.
Cancer Immunol Immunother. 2017 May;66(5):673-681. doi: 10.1007/s00262-017-1974-2. Epub 2017 Mar 1.
9
CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
Hum Vaccin Immunother. 2014;10(10):3090-100. doi: 10.4161/hv.29767.
10
CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.
Hum Vaccin Immunother. 2017 Oct 3;13(10):2272-2279. doi: 10.1080/21645515.2017.1358327.
本文引用的文献
1
In situ tumour arrays reveal early environmental control of cancer immunity.
Nature. 2023 Jun;618(7966):827-833. doi: 10.1038/s41586-023-06132-2. Epub 2023 May 31.
2
Microenvironmental signals shaping NK-cell reactivity in cancer.
Eur J Immunol. 2023 Dec;53(12):e2250103. doi: 10.1002/eji.202250103. Epub 2023 May 28.
3
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
Nature. 2023 Jun;618(7963):144-150. doi: 10.1038/s41586-023-06063-y. Epub 2023 May 10.
4
Bispecific T cell-engager targeting oncofetal chondroitin sulfate induces complete tumor regression and protective immune memory in mice.
J Exp Clin Cancer Res. 2023 Apr 28;42(1):106. doi: 10.1186/s13046-023-02655-8.
5
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8 T cells.
Nat Immunol. 2023 May;24(5):869-883. doi: 10.1038/s41590-023-01477-2. Epub 2023 Apr 20.
6
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses.
Science. 2023 Feb 17;379(6633):eabg2752. doi: 10.1126/science.abg2752.
7
Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements.
Sci Immunol. 2023 Feb 3;8(80):eabm6360. doi: 10.1126/sciimmunol.abm6360.
8
Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancer.
Sci Immunol. 2023 Feb 3;8(80):eabm6359. doi: 10.1126/sciimmunol.abm6359.
9
Influence of circadian clocks on adaptive immunity and vaccination responses.
Nat Commun. 2023 Jan 30;14(1):476. doi: 10.1038/s41467-023-35979-2.
10
Autologous T cell therapy for MAGE-A4 solid cancers in HLA-A*02 patients: a phase 1 trial.
Nat Med. 2023 Jan;29(1):104-114. doi: 10.1038/s41591-022-02128-z. Epub 2023 Jan 9.
Zotero 插件